Regions
Q&A: Navegar's Honorio Poblador
Honorio Poblador, co-founder at Philippines-based Navegar, explains how his firm is positioning its second fund – newly closed at $197 million – in the face of the COVID-19 downturn
China cancer test kit provider gets $30m Series E
New Horizon Health, a China-based manufacturer of cancer testing kits for use at home, has raised $30 million in a Series E round of funding led by Rock Springs Capital.
China's Yingke PE raises $286m
Shanghai-based Yingke Private Equity has closed its latest renminbi-denominated fund with commitments of RMB2 billion ($286 million), primarily from insurers and other financial institutions.
Google commits $10b for India digitization effort
Google will launch a INR750 billion ($10 billion) fund to make equity, operational, infrastructure and ecosystem investments that seek to increase the pace of digitization in India.
Large-cap vehicles support PE fundraising revival in second quarter
Asia private equity fundraising rebounded from a seven-year low in the first quarter of the year to reach $24 billion for April through June, but commitments were concentrated on a handful of managers.
Ocumension climbs on debut after $184m Hong Kong IPO
Ocumension Therapeutics, a Chinese drug developer targeting eye diseases that counts Boyu Capital and Temasek Holdings among its backers, posted a 152% gain on debut following a HK$1.5 billion ($200 million) Hong Kong IPO.
Quan leads $80m Series A for China biotech player
Healthcare-focused VC firm Quan Capital has led an $80 million Series A round for Citrine Medicine, a Chinese biotech developer set up by Eight Roads, F-Prime Capital, and Vivo Capital.
China EV maker Li Auto pursues US listing
Li Auto, a Chinese electric vehicle manufacturer that has been backed by online-to-offline (O2O) services giant Meituan Dianping, has filed for a US IPO.
Qualcomm Ventures invests $97m in India’s Jio Platforms
Qualcomm Ventures has agreed to invest INR7.3 billion ($97 million) in India’s Jio Platforms, the holding company for various internet and telecom assets owned by Reliance Industries.
Deal focus: Cortina goes natural for debut Australia deal
Cross-border PE investor Cortina Capital has backed Australian nutritional supplements producer ATP Science with an eye to China expansion. But establishing brand recognition at home is the first step
Lawmakers endorse Hong Kong's fund domicile ambitions
Hong Kong’s updated limited partnership legislation has passed into law, giving private equity and venture capital managers the option of domiciling their funds in the territory.
Portfolio: CBC Group and I-Mab Biopharma
CBC Group’s stewardship of I-Mab Biopharma brings an intensely hands-on platform-based approach to a booming China biotech space often characterized by relatively passive strategies
China's Newlink raises $128m Series D
Newlink Group, operator of a platform that helps drivers in China locate the best value gas stations, has raised a RMB900 million ($128 million) Series D round led by CICC Capital. Xiaomi Corporation also participated.
China’s Harbour BioMed raises $103m Series C
Chinese biotech start-up Harbour BioMed has raised $102.8 million in Series C funding. It comes four months after it closed an extended Series B round of $75 million.
VinaCapital, Daiwa sell stake in Vietnam dairy producer
Vietnam’s VinaCapital and Japan’s Daiwa PI Partners are poised to make a partial exit from Vietnamese dairy producer International Dairy Products (IDP).
China gay dating app Blued raises $85m in US IPO
BlueCity Holdings, the VC-backed holding company for Chinese gay dating platform Blued, traded strongly after raising $84.8 million through a NASDSAQ IPO.
Deal focus: J-Star maneuvers Japan’s restaurant lull
J-Star's acquisition of Pepper Lunch is driven by a willingness to look past COVID-19 dislocations and focus on the long-term fundamentals of the fast-casual dining space in Japan
Korea's ACE Equity launches SPAC targeting IT infrastructure
Korean private equity firm ACE Equity Partners has taken another step in the development of its cross-border investment capabilities with the launch of a US-listed special purpose acquisition company (SPAC) to pursue IT infrastructure assets.
Chinese online art tutoring platform secures $40m
Meishubao, China’s leading online art education platform, has raised $40 million in an extended Series C round led by Tencent Holdings.
Sequoia leads $100m Series C for China's Kuaidian
Kuaidian, a Chinese interactive content provider, has raised close to $100 million in Series C funding led by Sequoia Capital China. Existing investors GGV Capital and Morningside Venture Capital re-upped.
Warburg Pincus set for part-exit from Jinxin Fertility
Warburg Pincus will sell an approximately 5.5% interest in Hong Kong-listed IVF services provider Jinxin Fertility for about HK$1.5 billion ($194 million) through a share placement.
CLSA looks to connect wealthy investors with unicorns
CLSA, the international arm of China-based brokerage CITIC Securities, has launched a strategy to offer high net worth clients investment opportunities in late-stage private companies in Asia.
DCM raises $880m for early-stage funds
DCM Ventures has raised $880 million across two funds that will continue its early-stage technology strategy, with 70% of the capital earmarked for deployment in China.
China IPOs: Star attraction
Having previously focused on offshore IPOs, China managers with US dollar funds are now considering the Star Market. But going onshore means more regulation as well as high valuations